This study is a prospective, multicenter phase II study with patients receiving
haploidentical transplantation for Severe Aplastic Anemia (SAA). The primary objective is to
assess overall survival (OS) at 1 year post-hematopoietic stem cell transplantation (HSCT).
Phase:
Phase 2
Details
Lead Sponsor:
Medical College of Wisconsin
Collaborators:
Blood and Marrow Transplant Clinical Trials Network National Cancer Institute (NCI) National Heart, Lung, and Blood Institute (NHLBI) National Marrow Donor Program